Bivalirudin called safe and effective in HIT

WASHINGTON – Bivalirudin is an attractive off-label option for the treatment of heparin-induced thrombocytopenia, Dr. Lee Joseph said at the annual meeting of the American College of Cardiology....

Field of Interest: Cardiology
Type: News Item

A fib–associated stroke jumped 42% in 2000s

WASHINGTON – A third more Americans were hospitalized for ischemic stroke in 2010 than 7 years before, and the incidence of stroke associated with atrial fibrillation grew even more sharply, up by...

Field of Interest: Cardiology
Type: News Item

Even mild preop sepsis boosts postop thrombosis risk

WASHINGTON – Preoperative sepsis proved to be an important independent risk factor for both arterial and venous thrombosis during or after surgery in an analysis of nearly 1.75 million U.S. surgical...

Field of Interest: Cardiology
Type: News Item

ACC/AHA cardiovascular risk equations get a thumbs-up

WASHINGTON – The controversial cardiovascular risk estimator introduced in the current American College of Cardiology/American Heart Association risk-assessment guidelines demonstrated "moderate...

Field of Interest: Cardiology
Type: News Item

FDA expands uses for cardiac resynchronization devices

The approval of cardiac resynchronization pacemakers and defibrillators manufactured by Medtronic has been expanded to include patients with atrioventricular block and less severe heart failure, the...

Field of Interest: Cardiology
Type: News Item

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.